Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Cost of Revenue: 2019-2025

Historic Cost of Revenue for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $2.5 million.

  • CureVac N.V's Cost of Revenue fell 94.29% to $2.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $29.1 million, marking a year-over-year decrease of 83.20%. This contributed to the annual value of $113.1 million for FY2024, which is 15.49% down from last year.
  • As of Q2 2025, CureVac N.V's Cost of Revenue stood at $2.5 million, which was up 172.04% from $920,399 recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Cost of Revenue registered a high of $135.6 million during Q3 2021, and its lowest value of $920,399 during Q1 2025.
  • Moreover, its 3-year median value for Cost of Revenue was $25.3 million (2024), whereas its average is $25.3 million.
  • Per our database at Business Quant, CureVac N.V's Cost of Revenue surged by 5,885,599.71% in 2021 and then tumbled by 97.97% in 2025.
  • CureVac N.V's Cost of Revenue (Quarterly) stood at $80.1 million in 2021, then rose by 1.90% to $81.6 million in 2022, then dropped by 29.35% to $57.7 million in 2023, then crashed by 97.25% to $1.6 million in 2024, then plummeted by 94.29% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q2 2025, $920,399 for Q1 2025, and $1.6 million during Q4 2024.